Evidence map›Paper›PMID 18572632›Full record

ReviewJournal of nanoscience and nanotechnology2008

The use of ultrasound and micelles in cancer treatment.

Ghaleb A Husseini, William G Pitt

Open access · greenAbstract readReview
In one paragraph

Review in Journal of nanoscience and nanotechnology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 73 citations in OpenAlex.

  1. Low-Frequency Sonophoresis: A Promising Strategy for Enhanced Transdermal Delivery.Advances in pharmacological and pharmaceutical sciences · 2024
    Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Acoustic droplet vaporization in biology and medicine.BioMed research international · 2013
    Review
  11. Nanoparticle delivery enhancement with acoustically activated microbubbles.IEEE transactions on ultrasonics, ferroelectrics, and frequency control · 2013
    Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Ghaleb A HusseiniChemical Engineering Department, American University of Sharjah, Sharjah, United Arab Emirates.
William G Pitt
American University of Sharjah · AEBrigham Young University · US

Funding

Controlled Drug Delivery to Colon Tumors Via UltrasoundR01CA098138 · NCI · BRIGHAM YOUNG UNIVERSITY · PI PITT, WILLIAM G · 2004 to 2006
$713k
NCI NIH HHS CA 98138NCI NIH HHS R01 CA098138
6 · The paper itself

Abstract

The high toxicity of potent chemotherapeutic drugs like Doxorubicin (Dox) limits the therapeutic window in which they can be applied. This window can be expanded by controlling the drug delivery in both space and time such that non-targeted tissues are not adversely affected. Recent research has shown that ultrasound (US) can be used to control the release of Dox and other hydrophobic drugs from polymeric micelles in both time and space. It has also been shown using an in vivo rat tumor model that Dox activity can be enhanced by ultrasound in one region, while in an adjacent region there is little or no effect of the drug. In this article, we review the in vivo and in vitro research being conducted in the area of using ultrasound to enhance and target micellar drug delivery to cancerous tissues. Additionally, we summarize our previously published mathematical models that attempt to represent the release and re-encapsulation phenomena of Dox from Pluronic P105 micelles upon the application of ultrasound. The potential benefits of such controlled chemotherapy compels a thorough investigation of the role of ultrasound (US) and the mechanisms by which US accomplishes drug release and/or enhances drug potency. Therefore we will summarize our findings related to the mechanism involved in acoustically activated micellar drug delivery to tumors.

Indexed as

Drug Delivery SystemsMicellesUltrasonicsAnimalsAntineoplastic AgentsHumansNeoplasmsAntineoplastic AgentsMicelles

Identifiers

PMID18572632
PMCPMC2519605
OpenAlexW2017532125

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.